Simret Beraki

Rani Therapeutics (United States)

Papers

1

Total Citations

94

H-Index

1

About

Simret Beraki is a pioneering researcher in the field of biotherapeutic drug delivery, with a primary focus on developing non-invasive oral alternatives to chronic injections. Her most notable contribution is the co-development of a robotic pill for oral delivery of biotherapeutics, a breakthrough that addresses the critical challenge of patient non-compliance due to pain and inconvenience. In a landmark 2021 study (94 citations), Beraki and her team demonstrated the safety, tolerability, and performance of this innovative device in healthy subjects, showing its potential to protect biotherapeutics from degradation in the gastrointestinal tract. This work represents a significant leap toward replacing painful injections with a patient-friendly oral platform, particularly for chronic diseases requiring frequent dosing. Beraki’s research bridges biomedical engineering and clinical pharmacology, offering a transformative solution to a long-standing problem in drug delivery. Her findings have garnered attention from both academic and pharmaceutical communities, positioning her as a rising leader in the quest to make biotherapeutics more accessible and tolerable for patients worldwide.

Research Focus

Key Achievements

1
H-Index
1
Papers
94
Total Citations
94
Avg Citations/Paper
🏆 Most Cited Paper
A robotic pill for oral delivery of biotherapeutics: safety, tolerability, and performance in healthy subjects
94 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 25
🏛 Institutions: Rani Therapeutics (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago